4-pyridin-4-yl-3H-1,3-thiazole-2-thione

We are 4-pyridin-4-yl-3H-1,3-thiazole-2-thione CAS:77168-63-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-pyridin-4-yl-3H-1,3-thiazole-2-thione
CAS.NO:77168-63-9
Synonyms:4-(4-Pyridinyl)thiazole-2-thiol
4-(4-pyridyl)-1,3-thiazole-2-thiol 
4-(pyridin-4-yl)-1,3-thiazole-2-thiol
2-mercapto-4-(pyridine-4-yl)thiazole
[4-(4-pyridyl)-1,3-thiazol-2-yl]thiol
Molecular Formula:C8H6N2S2
Molecular Weight:194.27700
 
Physical and Chemical Properties:
Density:1.356
Boiling point:356.135ºC
Flash point:169.184ºC
Index of Refraction:1.671
 
Specification:
Appearance:Off-white to light yellow powder
Purity:≥98.5%
Loss on drying:≤0.5%
Total impurities:≤1.0%
Largest single impurity:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For the synthesis of ceftaroline

4-pyridin-4-yl-3H-1,3-thiazole-2-thione


Related News: With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.1010-60-2 China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.1-(Mesitylene-2-sulfonyl)-3-nitro-1,2,4-triazole CAS:74257-00-4 On the other hand, the company has many new products in recent years, including Duqiao Base, Yancheng United Chemical and Dezhou United Chemical. These new products are mostly customized products with strong profitability, which has improved the gross profit margin of the industrial business.5-Fluoropicolinic acid Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.

Related Products
Product Name
dibenzofuran-4,6-bis-(boronic acid) View Details
2-Chloro-3-fluoro-5-nitropyridine View Details
1-Acetyl-5-(2-aminopropyl)-2,3-dihydro-1H-indole-7-carbonitrile View Details
Ethyl(ethoxymethylene)cyanoacetate manufacturer a,a-Dichloro-N,N-Diethylacetylacetamide manufacturer Ethenyldiethoxymethylsilane manufacturer Pentachlorobenzonitrile manufacturer 1-[2-(2-Hydroxyethoxy)Ethyl]Piperidine manufacturer